Glenmark launches Clindamycin Phosphate Foam EP News Bureau Feb 12, 2025 The new product targets a market worth $5.8 million
Glenmark Pharma gets tentative nod from US FDA for acne treatment drug EP News Bureau Jun 21, 2019 The drug, Clindamycin Phosphate Foam, 1 per cent, is a generic version of Mylan Pharmaceuticals' Evoclin Foam
